The financial terms of the deal were not disclosed.
Polymer Conversions is a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. Its offerings complement Medbio, which specializes in cleanroom injection molding of plastic components for the medical and biotechnology industries.
“I’m looking forward to partnering with the PCI team to expand Medbio’s manufacturing capabilities, while reaching new customers and end markets,” Medbio CEO Chris Williams said in a news release.
Medbio is a portfolio company of Graham Partners, a private investment firm with a specialty in industrial technology and advanced manufacturing companies.